IBDEI0OT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11593,1,3,0)
 ;;=3^Cerebrovascular Disease,Facial Weakness
 ;;^UTILITY(U,$J,358.3,11593,1,4,0)
 ;;=4^I69.992
 ;;^UTILITY(U,$J,358.3,11593,2)
 ;;=^5007570
 ;;^UTILITY(U,$J,358.3,11594,0)
 ;;=I69.923^^47^534^23
 ;;^UTILITY(U,$J,358.3,11594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11594,1,3,0)
 ;;=3^Cerebrovascular Disease,Fluency Disorder
 ;;^UTILITY(U,$J,358.3,11594,1,4,0)
 ;;=4^I69.923
 ;;^UTILITY(U,$J,358.3,11594,2)
 ;;=^5007556
 ;;^UTILITY(U,$J,358.3,11595,0)
 ;;=I69.952^^47^534^24
 ;;^UTILITY(U,$J,358.3,11595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11595,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Left Dominant Side
 ;;^UTILITY(U,$J,358.3,11595,1,4,0)
 ;;=4^I69.952
 ;;^UTILITY(U,$J,358.3,11595,2)
 ;;=^5133586
 ;;^UTILITY(U,$J,358.3,11596,0)
 ;;=I69.954^^47^534^25
 ;;^UTILITY(U,$J,358.3,11596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11596,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,11596,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,11596,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,11597,0)
 ;;=I69.951^^47^534^26
 ;;^UTILITY(U,$J,358.3,11597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11597,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Right Dominant Side
 ;;^UTILITY(U,$J,358.3,11597,1,4,0)
 ;;=4^I69.951
 ;;^UTILITY(U,$J,358.3,11597,2)
 ;;=^5007561
 ;;^UTILITY(U,$J,358.3,11598,0)
 ;;=I69.953^^47^534^27
 ;;^UTILITY(U,$J,358.3,11598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11598,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,11598,1,4,0)
 ;;=4^I69.953
 ;;^UTILITY(U,$J,358.3,11598,2)
 ;;=^5007562
 ;;^UTILITY(U,$J,358.3,11599,0)
 ;;=I69.942^^47^534^28
 ;;^UTILITY(U,$J,358.3,11599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11599,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Dominant Side
 ;;^UTILITY(U,$J,358.3,11599,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,11599,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,11600,0)
 ;;=I69.944^^47^534^29
 ;;^UTILITY(U,$J,358.3,11600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11600,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Nondominant Side
 ;;^UTILITY(U,$J,358.3,11600,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,11600,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,11601,0)
 ;;=I69.932^^47^534^30
 ;;^UTILITY(U,$J,358.3,11601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11601,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,11601,1,4,0)
 ;;=4^I69.932
 ;;^UTILITY(U,$J,358.3,11601,2)
 ;;=^5133580
 ;;^UTILITY(U,$J,358.3,11602,0)
 ;;=I69.934^^47^534^31
 ;;^UTILITY(U,$J,358.3,11602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11602,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,11602,1,4,0)
 ;;=4^I69.934
 ;;^UTILITY(U,$J,358.3,11602,2)
 ;;=^5133583
 ;;^UTILITY(U,$J,358.3,11603,0)
 ;;=I69.941^^47^534^32
 ;;^UTILITY(U,$J,358.3,11603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11603,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Lower Dominant Side
 ;;^UTILITY(U,$J,358.3,11603,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,11603,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,11604,0)
 ;;=I69.943^^47^534^33
 ;;^UTILITY(U,$J,358.3,11604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11604,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,11604,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,11604,2)
 ;;=^5133584
